Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141180 · ClinicalTrials.gov registry record · Phase 1
CP-481,715 Nickel Allergy Study.
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00141180 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 48 participants.
The verdict
NCT00141180, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.
Interventions
- DRUG CP-481,715
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00141180
The ClinicalTrials.gov registry entry for NCT00141180 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CP-481,715 is the first listed.
NCT00141180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00141180 about?
NCT00141180 is a clinical study titled "CP-481,715 Nickel Allergy Study.". To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.
What is the current status of trial NCT00141180?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2003-09. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00141180?
The interventions under investigation include: CP-481,715 (DRUG).
Who is sponsoring clinical trial NCT00141180?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.